A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT06925100
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT06925100
-
- Other papers using this trial's data
- Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients With Hypercholesterolemia: A Pragmatic Phase 4 Study (CLEAR Taiwan Study)
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT06925100. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-01 (actual); primary completion 2025-10-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan
- Acronym
- CLEAR Taiwan
- Condition
- Primary Hypercholesterolemia or Mixed Hyperlipidemia
- Intervention (Drug)
- Bempedoic acid 180 mg tablet
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct06925100- Content hash
ae2ffb0d655bb3c5ccd31b9cdbb705df5a0aee39d4b3542221cd4a3a061ec065